Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Change-In-Working-Capital" stands at 6.62 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 12/31/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -2.53 Billion Hong Kong Dollars compared to the value the year prior.
The 1 year change is -2.53 Billion Hong Kong Dollars.
The 3 year change is 2.81 Billion Hong Kong Dollars.
The 5 year change is -0.2651 Billion Hong Kong Dollars.
The 10 year change is 6.89 Billion Hong Kong Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change In Working Capital | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change In Working Capital | 486,508,953,600.00 |
![]() | AbbVie Inc - Change In Working Capital | 399,570,305,024.00 |
![]() | Roche Holding AG - Change In Working Capital | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change In Working Capital | 280,205,508,085.11 |